During the past decade, Lovelace Scientific Resources, Inc. conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 34 clinical trials were completed, i.e. on average, 141.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 21 clinical trials were completed. i.e. 1050% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lovelace Scientific Resources, Inc." #1 sponsor was "AstraZeneca" with 5 trials, followed by "Allergan" with 4 trials sponsored, "Bausch Health Americas, Inc." with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Evoke Pharma" with 3 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lovelace Scientific Resources, Inc." #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Clinquest, Inc." with 1 trials as a collaborator and "Ergomed" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Lovelace Scientific Resources, Inc." are "Diabetes Mellitus, Type 2" (6 trials), "Gastroparesis" (6 trials), "Diabetes Mellitus" (4 trials), "Diabetic Gastroparesis" (4 trials) and "Obesity" (4 trials). Many other conditions were trialed in "Lovelace Scientific Resources, Inc." in a lesser frequency.

Most popular intervention types in "Lovelace Scientific Resources, Inc." are "Drug" (58 trials), "Other" (3 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "placebo" (4 trials), "AC2993" (3 trials), "Relamorelin" (3 trials) and "Ancillary therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lovelace Scientific Resources, Inc." are 60 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Lovelace Scientific Resources, Inc.". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Lovelace Scientific Resources, Inc., undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Lovelace Scientific Resources, Inc., 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".